Filter
194
Filtered Results: 194
Text search:
National
Pharmacovigilance
and
Medicines
Information
Center
Featured
Recommendations
25
New Publications
59
Language
Document type
No document type
109
Guidelines
30
Studies & Reports
29
Manuals
11
Strategic & Response Plan
7
Training Material
3
Situation Updates
3
Fact sheets
2
Countries / Regions
Rwanda
10
Nigeria
10
Kenya
9
Ethiopia
9
Namibia
8
India
8
Ghana
7
South Africa
6
Nepal
5
Cambodia
5
Liberia
5
Philippines
4
Latin America and the Carribbean
4
Tanzania
4
Eastern Europe
4
Zambia
4
Mozambique
3
Western and Central Europe
3
Russia
3
Ukraine
2
Sierra Leone
2
Malawi
2
Africa
2
Asia
2
West and Central Africa
2
South–East Asia Region
2
Bangladesh
2
Uganda
2
Botswana
2
Indonesia
2
Pakistan
2
Thailand
1
Lesotho
1
Gambia
1
Cameroon
1
Laos
1
Senegal
1
Afghanistan
1
Zimbabwe
1
Haiti
1
Jordan
1
Middle East and North Africa
1
Western Pacific Region
1
East and Southern Africa
1
Argentina
1
Sri Lanka
1
Georgia
1
Libya
1
Bhutan
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
34
Policies & Guidelines HIV & TB
28
Policies
26
Guidelines
17
Studies & Reports
9
NTDs & Others
6
TB
5
Statistics
4
Pharmacy & Technology
3
Communicable Diseases
2
Vaccine-preventable Diseases
2
Pharmaceutical Assessments
2
NCD
2
Women & Child Health
2
Capacity Building
2
General Guidelines
2
Leprosy
2
Helminthiasis
1
Trachoma
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
Dermatology
1
Lymphaticfilariasis
1
Cancer
1
COVID-19
1
Pediatric cancer
1
Snakebites
1
Pediatrics
1
Countries
1
Medical Devices & Equipment
1
Clinical Guidelines
1
Respiratory Infections
1
Immunization
1
Health Systems
1
Primary Health Care
1
Non-communicable Diseases
1
Malaria
1
Disease Prevention & Control
1
Key Resources
1
Toolboxes
Country specific
7
Rational use of Medicine
7
Immunization Guidelines
6
Clinical Guidelines
5
Supporting tools
4
Hospital Readiness/Essential Health Services
4
Traditional & Herbal Medicines
4
Pharmacovigilance
4
Clinical Aspects, Treatment & Prevention
3
Country Specific
3
Pharmacy Practice
3
General Guidelines for Rational Use
3
Drug resistant TB
3
Antiretroviral Treatment ART
3
Treatment & Prevention
2
Adults
2
Ethiopia
2
Studies
2
General
2
Infection Control General
2
Access & Strategy
2
Essential Medicines
2
Falsified & Substandard
2
Pharmaceutical Assessments
2
Reports & Studies
2
Eastern Europe & Central Asia
2
Kenya
2
Reports & Studies
2
SEAR (South-east Asia Region)
2
Eastern Europe and central Asia
2
Clinical Guidelines
1
Clinical Aspects
1
Prevention & Control
1
Vaccination
1
Children & Adolescents
1
WPRO (Western Pacific Region)
1
Influenza
1
Namibia
1
HIV
1
Rwanda
1
TB & Other Vulnerable Populations
1
Children
1
Georgia
1
Drug resistance
1
Country Guidelines
1
International
1
Prevention & Preparedness
1
Context & Facts, Travel Advice
1
Surveillance & Contact tracing
1
Training, others
1
Gender Aspects
1
Oxygen Therapy
1
TB/HIV
1
Logistics & Supply
1
Fair Allocation & Ethical Aspects
1
COVAX Initiative
1
Biontech/Pfizer Comirnaty
1
Research & Pipeline
1
General documents One Health
1
Antimicrobial Resistance (AMR)
1
Non-communicable Diseases NCD
1
Heat
1
Capacity Building & Resources
1
Studies & Reports
1
Patient Safety
1
Overview, Studies & Reports
1
Clinical Aspects & Diagnosis
1
Diagnosis
1
Romania
1
Asia and Pacific
1
Co-Morbidities (except TB)
1
General Aspects
1
Regional Reports & Guidelines, others
1
Education of students & professionals
1
Research & Access
1
General Public
1
Clinical Guidelines
1
HIV service delivery
1
AmR (Region of Americas)
1
TB
1
Preparedness & Prevention
1
Treatment & Clinical Management
1
English version - This handbook sets out a the new paradigm for pharmacy practice. Its aim is to guide pharmacy educators in pharmacy practice, to educate pharmacy students and to guide pharmacists in practice to update their skills. The handbook, which brings together practical tools and knowledge,...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Mid-term review of The National AIDS Programme 2011-15
October 2013
Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups
recommended
Treating children infected with intestinal worms is one of the simplest and most cost–effective ways to improve their health.
The recommendations are intended for a wide audience, including policy-makers and their expert advisers as well as technical and programme staff at government institution...
The goal of the United States Government for the President's Emergency Plan for AIDS Relief (PEPFAR) in Mozambique is to support country efforts to achieve epidemic control by 2020 through evidence-based policies and interventions to drive progress and save
lives. This document details PEPFAR's op...
For the Fiscal Year 2015-2016, the Health Sector continued to implement actions meant to improve the availability, and access to quality healthcare. The following report highlights achievements registered by the health sector for the fiscal 2015-2016 in different health programs, as well as in the a...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
Interim guidance. 12 May 2021. The Continuity of essential health services: Facility Assessment Tool can be used by countries to rapidly assess the capacity of health facilities to maintain the provision of essential health services during the COVID-19 pandemic. It can help to alert the authorities ...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01 vaccine for the reduction of malaria morbidity and mortality in ...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
The World Health Organization's fourth Country Cooperation Strategy 2022-2026 is an outcome of a consultative process with inputs from the Ministry of Health, various agencies in the health sector, and other relevant stakeholders. It has been developed to provide strategic direction and support towa...
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
WHO Ghana 2022 annual report
recommended
“2022 was an eventful year for the WHO Country Office in Ghana,” says Dr Francis Kasolo, WHO Representative to Ghana.
In 2022, WHO Ghana collaborated with partners to deliver interventions in support of the Government of Ghana's health sector agenda to ensure healthy lives for all towards ach...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr...
The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for health workers’ education and training on AMR to ensure that academic institutions ...
